MedPath

Monteris Medical

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

8

Active:0
Completed:5

Trial Phases

2 Phases

Phase 1:2
Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (50.0%)
Phase 1
2 (50.0%)

REMASTer: REcurrent Brain Metastases After SRS Trial

Not Applicable
Recruiting
Conditions
Brain Metastases
Radiation Necrosis
Recurrent Tumor
Recurrent Metastases
Interventions
Procedure: Radiation Therapy
Procedure: Laser Interstitial Thermal Therapy
First Posted Date
2021-11-18
Last Posted Date
2025-07-23
Lead Sponsor
Monteris Medical
Target Recruit Count
261
Registration Number
NCT05124912
Locations
🇺🇸

UCLA, Los Angeles, California, United States

🇺🇸

University of Chicago, Chicago, Illinois, United States

🇺🇸

University of Maryland, Baltimore, Maryland, United States

and more 6 locations

PatiEnt Neuropsychological outcomeS After laseR Ablation

Completed
Conditions
Cognitive Change
First Posted Date
2021-10-13
Last Posted Date
2025-04-06
Lead Sponsor
Monteris Medical
Target Recruit Count
81
Registration Number
NCT05075850
Locations
🇺🇸

University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

🇺🇸

Advent Health Orlando, Orlando, Florida, United States

🇺🇸

University of Kansas Medical Center, Kansas City, Kansas, United States

and more 4 locations

Feasibility Study on LITT for Newly Diagnosed Glioblastoma

Phase 1
Terminated
Conditions
Glioblastoma
Interventions
Device: NeuroBlate System
Drug: Radiation therapy and temozolomide
First Posted Date
2016-08-26
Last Posted Date
2024-04-12
Lead Sponsor
Monteris Medical
Target Recruit Count
3
Registration Number
NCT02880410
Locations
🇺🇸

Washington University, Saint Louis, Missouri, United States

🇺🇸

Wake Forest Baptist Health, Winston-Salem, North Carolina, United States

🇺🇸

Cleveland Clinic Foundation, Cleveland, Ohio, United States

and more 1 locations

Feasibility Study on LITT for Medical Refractory Epilepsy

Not Applicable
Terminated
Conditions
Epilepsy
First Posted Date
2016-07-01
Last Posted Date
2024-07-12
Lead Sponsor
Monteris Medical
Target Recruit Count
4
Registration Number
NCT02820740
Locations
🇺🇸

St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States

🇺🇸

Yale University School of Medicine, New Haven, Connecticut, United States

🇺🇸

University of Kansas Medical Center, Kansas City, Kansas, United States

and more 2 locations

Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System

Completed
Conditions
Primary Brain Tumor
Epileptic/Seizure Foci
Metastatic Brain Tumor
Movement Disorders
First Posted Date
2015-03-18
Last Posted Date
2025-04-24
Lead Sponsor
Monteris Medical
Target Recruit Count
1153
Registration Number
NCT02392078
Locations
🇺🇸

Barrow Neurological Institute at Dignity Health St. Joseph's Hospital & Medical Center, Phoenix, Arizona, United States

🇺🇸

University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

🇺🇸

University of California, San Diego, La Jolla, California, United States

and more 23 locations
  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.